Aemetis AMTX shares are trading higher on Tuesday after the company announced it received an FDA national drug code for its OTC sanitizer products.
Aemetis is an international renewable fuel and biochemicals company focused on the production of advanced renewable fuels & chemicals through the acquisition, development & commercialization of innovative technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates a approximately 60 million gallon per year ethanol production facility located in Keyes, California.
Aemetis's stock traded up 27.07% at $2.11 per share at the time of publication on Tuesday. The stock has a 52-week high of $3.47 and a 52-week low of 37 cents.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.